Barostim access broadens with RWJBarnabas Health and CVRx partnership

Barostim access broadens with RWJBarnabas Health and CVRx partnership
CVRx expands Barostim access

CVRx announced an expansion of access to its Barostim therapy for patients with heart failure, supported by RWJBarnabas Health. The company recognized Dr. Kulpreet Barn, Dr. Jagpreet Grewal, Dr. Mahmoud Ghusson, Dr. Justin Fox, Dr. Honest Poblete, and the medical team at Robert Wood Johnson University Hospital for their collaboration.

This initiative aims to enhance treatment options for individuals living with heart failure. CVRx continues to deepen its partnerships with major hospital systems to improve access to innovative therapies across the U.S. healthcare landscape.

CVRx previously acknowledged Christus Trinity Mother Frances for reaching its tenth Barostim implant milestone in heart failure care. The company also hosted a symposium at AAHFN2026 focused on clinical integration of Barostim. These initiatives highlight ongoing efforts to expand Barostim therapy in collaboration with healthcare providers.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.